Author already exited for profit and warns of double top risk. External data shows +80% spike on $5M buyback news (tiny $5.5M market cap biotech). Post celebrates past gain but cautions on continuation—not a current bullish call. This is post-trade celebration of a momentum pop, not a forward bullish thesis.